Pei‐Ling Hsu

2.7k total citations
78 papers, 2.1k citations indexed

About

Pei‐Ling Hsu is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Pei‐Ling Hsu has authored 78 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 27 papers in Immunology and 11 papers in Oncology. Recurrent topics in Pei‐Ling Hsu's work include Lymphoma Diagnosis and Treatment (9 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and T-cell and Retrovirus Studies (5 papers). Pei‐Ling Hsu is often cited by papers focused on Lymphoma Diagnosis and Treatment (9 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and T-cell and Retrovirus Studies (5 papers). Pei‐Ling Hsu collaborates with scholars based in United States, Taiwan and China. Pei‐Ling Hsu's co-authors include Su-Ming Hsu, S M Hsu, S M Hsu, Shaw‐Jenq Tsai, Wilma Ross, Arthur Landy, Su-Su Xie, Fan‐E Mo, Shih‐Chieh Lin and Wen‐Tai Chiu and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Circulation.

In The Last Decade

Pei‐Ling Hsu

73 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pei‐Ling Hsu United States 27 742 504 385 369 215 78 2.1k
Min‐Geol Lee South Korea 26 706 1.0× 768 1.5× 480 1.2× 204 0.6× 340 1.6× 157 2.6k
Jennifer J. Brady Ireland 30 1.7k 2.2× 465 0.9× 594 1.5× 378 1.0× 164 0.8× 62 3.3k
Yoshiyuki Takahara Japan 17 815 1.1× 961 1.9× 679 1.8× 150 0.4× 153 0.7× 28 2.4k
Stephan Böhm Germany 30 1.2k 1.6× 489 1.0× 367 1.0× 170 0.5× 217 1.0× 73 3.8k
Min Kim South Korea 32 1.3k 1.7× 309 0.6× 732 1.9× 169 0.5× 210 1.0× 219 3.8k
David Engler United States 27 938 1.3× 194 0.4× 311 0.8× 204 0.6× 151 0.7× 68 1.9k
Héctor Martínez-Valdez United States 23 747 1.0× 1.1k 2.2× 300 0.8× 233 0.6× 136 0.6× 48 2.2k
G. Romeo Italy 31 1.3k 1.8× 705 1.4× 473 1.2× 128 0.3× 140 0.7× 144 2.9k
Suk Kyeong Lee South Korea 28 892 1.2× 474 0.9× 1.3k 3.2× 422 1.1× 178 0.8× 88 2.6k
G Laurent France 36 2.2k 2.9× 594 1.2× 1.0k 2.6× 470 1.3× 176 0.8× 116 4.1k

Countries citing papers authored by Pei‐Ling Hsu

Since Specialization
Citations

This map shows the geographic impact of Pei‐Ling Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pei‐Ling Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pei‐Ling Hsu more than expected).

Fields of papers citing papers by Pei‐Ling Hsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pei‐Ling Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pei‐Ling Hsu. The network helps show where Pei‐Ling Hsu may publish in the future.

Co-authorship network of co-authors of Pei‐Ling Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Pei‐Ling Hsu. A scholar is included among the top collaborators of Pei‐Ling Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pei‐Ling Hsu. Pei‐Ling Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hsu, Pei‐Ling, et al.. (2025). Impact of Tenofovir Alafenamide on Lipid Profiles in Chronic Hepatitis B Patients: Systematic Review and Meta‐Analysis. Journal of Medical Virology. 97(4). e70331–e70331.
4.
Hung, Hao‐Chang, et al.. (2023). Dietary fatty acids differentially affect secretion of pro-inflammatory cytokines in human THP-1 monocytes. Scientific Reports. 13(1). 5511–5511. 18 indexed citations
5.
6.
Tsai, Sheng‐Feng, Pei‐Ling Hsu, Yun‐Wen Chen, et al.. (2022). High-fat diet induces depression-like phenotype via astrocyte-mediated hyperactivation of ventral hippocampal glutamatergic afferents to the nucleus accumbens. Molecular Psychiatry. 27(11). 4372–4384. 37 indexed citations
7.
Juang, Shin‐Hun, Min‐Tsang Hsieh, Pei‐Ling Hsu, et al.. (2020). Studies of Coumarin Derivatives for Constitutive Androstane Receptor (CAR) Activation. Molecules. 26(1). 164–164. 5 indexed citations
8.
Hsiao, Kuei‐Yang, Chu-An Wang, Ning Chang, et al.. (2020). Extracellular vesicle-associated VEGF-C promotes lymphangiogenesis and immune cells infiltration in endometriosis. Proceedings of the National Academy of Sciences. 117(41). 25859–25868. 51 indexed citations
9.
Su, Bor‐Chyuan, Pei‐Ling Hsu, & Fan‐E Mo. (2019). CCN1 triggers adaptive autophagy in cardiomyocytes to curb its apoptotic activities. Journal of Cell Communication and Signaling. 14(1). 93–100. 16 indexed citations
10.
Ling, Yong, Yu‐Ning Teng, Shi Chen, et al.. (2018). Development of novel amino-quinoline-5,8-dione derivatives as NAD(P)H:quinone oxidoreductase 1 (NQO1) inhibitors with potent antiproliferative activities. European Journal of Medicinal Chemistry. 154. 199–209. 31 indexed citations
11.
Lee, Su‐Shin, et al.. (2008). Experiences of Interprofessional Implementation of a Healthcare Matrix. The Kaohsiung Journal of Medical Sciences. 24(12). 634–639. 10 indexed citations
12.
Hsu, Pei‐Ling & Su-Ming Hsu. (2000). Autocrine Growth Regulation of CD30 Ligand in CD30-Expressing Reed-Sternberg Cells: Distinction Between Hodgkin's Disease and Anaplastic Large Cell Lymphoma. Laboratory Investigation. 80(7). 1111–1119. 35 indexed citations
13.
Zeichner‐David, M, Haiyan Tan, Thomas G.H. Diekwisch, et al.. (1997). Timing of the expression of enamel gene products during mouse tooth development. The International Journal of Developmental Biology. 41(1). 27–38. 68 indexed citations
14.
Hsu, Su-Ming, et al.. (1996). Hodgkin's disease and anaplastic large cell lymphoma revisited. Journal of Biomedical Science. 3(1). 1–13. 6 indexed citations
15.
Hsu, Su-Ming, et al.. (1995). Hodgkin's disease and anaplastic large cell lymphoma revisited. Journal of Biomedical Science. 2(4). 302–313. 23 indexed citations
16.
Hsu, Su-Ming & Pei‐Ling Hsu. (1994). The Nature of Reed-Sternberg Cells: Phenotype, Genotype, and Other Properties. Critical Reviews™ in Oncogenesis. 5(2-3). 213–245. 32 indexed citations
17.
Fink, Louis M. & Pei‐Ling Hsu. (1994). Bacteriophage epitope libraries. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 424(1). 1–6. 1 indexed citations
18.
Sell, Stewart & Pei‐Ling Hsu. (1993). Delayed hypersensitivity, immune deviation, antigen processing and T-cell subset selection in syphilis pathogenesis and vaccine design. Immunology Today. 14(12). 576–582. 26 indexed citations
19.
Hsu, Su-Ming, et al.. (1993). Cytokines in malignant lymphomas: Review and prospective evaluation. Human Pathology. 24(10). 1040–1057. 107 indexed citations
20.
Hsu, Su-Ming, Jin Lin, Su-Su Xie, Pei‐Ling Hsu, & Stephen S. Rich. (1993). Abundant expression of transforming growth factor-β1 and -β2 by Hodgkin's reed-sternberg cells and by reactive T lymphocytes in Hodgkin's disease. Human Pathology. 24(3). 249–255. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026